Acute respiratory distress syndrome (ARDS) is an acute respiratory illness characterised by
bilateral chest radiographical opacities with severe hypoxaemia due to non-cardiogenic …

Acute respiratory distress syndrome (ARDS) occurs when a diverse array of triggers cause
acute, bilateral pulmonary inflammation and increased pulmonary capillary permeability …

We congratulate Giacomo Grasselli and colleagues for their important and informative work
on the pathophysiology of COVID-19-associated acute respiratory distress syndrome …

One of the most common causes of hospital admission and death in patients with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is acute respiratory …

Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome historically
characterized by the presence of severe hypoxemia, high-permeability pulmonary edema …

The outbreak of coronavirus disease 2019 (COVID-19) in December 2019 in the city of
Wuhan in Mainland China has spread across the globe with> 100,000 infected individuals …

Background Patients with COVID-19 can develop acute respiratory distress syndrome
(ARDS), which is associated with high mortality. The aim of this study was to examine the …

The COVID-19 pandemic has seen a surge of patients with acute respiratory distress
syndrome (ARDS) in intensive care units across the globe. As experience of managing …

Acute respiratory distress syndrome (ARDS) is a complex syndrome of acute lung injury
leading to noncardiogenic pulmonary edema from many causes that is heterogenous in its …

Background In acute respiratory distress syndrome (ARDS) unrelated to COVID-19, two
phenotypes, based on the severity of systemic inflammation (hyperinflammatory and …